{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:39:07Z","timestamp":1793403547094,"version":"4.5.0"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T00:00:00Z","timestamp":1551830400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T00:00:00Z","timestamp":1551830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1038\/s41574-019-0180-z","type":"journal-article","created":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T12:05:04Z","timestamp":1551873904000},"page":"299-311","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["Overgrowth syndromes \u2014 clinical and molecular aspects and tumour risk"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8122-760X","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Brioude","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5999-5300","authenticated-orcid":false,"given":"Annick","family":"Toutain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloise","family":"Giabicani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Cottereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Cormier-Daire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Netchine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,6]]},"reference":[{"key":"180_CR1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/ejhg.2015.88","volume":"24","author":"A Mussa","year":"2016","unstructured":"Mussa, A. et al. (Epi)genotype-phenotype correlations in Beckwith-Wiedemann syndrome. Eur. J. Hum. Genet. 24, 183\u2013190 (2016).","journal-title":"Eur. J. Hum. Genet."},{"key":"180_CR2","doi-asserted-by":"crossref","first-page":"S745","DOI":"10.1016\/j.ajog.2017.11.577","volume":"218","author":"GJ Burton","year":"2018","unstructured":"Burton, G. J. & Jauniaux, E. Pathophysiology of placental-derived fetal growth restriction. Am. J. Obstet. Gynecol. 218, S745\u2013S761 (2018).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"180_CR3","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrendo.2012.96","volume":"8","author":"TA Buchanan","year":"2012","unstructured":"Buchanan, T. A., Xiang, A. H. & Page, K. A. Gestational diabetes mellitus: risks and management during and after pregnancy. Nat. Rev. Endocrinol. 8, 639\u2013649 (2012).","journal-title":"Nat. Rev. Endocrinol."},{"key":"180_CR4","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ajhg.2017.03.010","volume":"100","author":"K Tatton-Brown","year":"2017","unstructured":"Tatton-Brown, K. et al. Mutations in epigenetic regulation genes are a major cause of overgrowth with intellectual disability. Am. J. Hum. Genet. 100, 725\u2013736 (2017).","journal-title":"Am. J. Hum. Genet."},{"key":"180_CR5","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1101\/gad.9.6.650","volume":"9","author":"S Matsuoka","year":"1995","unstructured":"Matsuoka, S. et al. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9, 650\u2013662 (1995).","journal-title":"Genes Dev."},{"key":"180_CR6","doi-asserted-by":"crossref","first-page":"E1055","DOI":"10.3390\/ijms19041055","volume":"19","author":"E Stampone","year":"2018","unstructured":"Stampone, E. et al. Genetic and epigenetic control of CDKN1C expression: importance in cell commitment and differentiation, tissue homeostasis and human diseases. Int. J. Mol. Sci. 19, E1055 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"180_CR7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/MOP.0000000000000379","volume":"28","author":"E Giabicani","year":"2016","unstructured":"Giabicani, E., Netchine, I. & Brioude, F. New clinical and molecular insights into Silver-Russell syndrome. Curr. Opin. Pediatr. 28, 529\u2013535 (2016).","journal-title":"Curr. Opin. Pediatr."},{"key":"180_CR8","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/ng.2275","volume":"44","author":"VA Arboleda","year":"2012","unstructured":"Arboleda, V. A. et al. Mutations in the PCNA-binding domain of CDKN1C cause IMAGe syndrome. Nat. Genet. 44, 788\u2013792 (2012).","journal-title":"Nat. Genet."},{"key":"180_CR9","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/ejhg.2015.224","volume":"24","author":"T Eggermann","year":"2016","unstructured":"Eggermann, T. et al. Prenatal molecular testing for Beckwith-Wiedemann and Silver-Russell syndromes: a challenge for molecular analysis and genetic counseling. Eur. J. Hum. Genet. 24, 784\u2013793 (2016).","journal-title":"Eur. J. Hum. Genet."},{"key":"180_CR10","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/gim.2017.105","volume":"20","author":"W Abi Habib","year":"2018","unstructured":"Abi Habib, W. et al. Genetic disruption of the oncogenic HMGA2-PLAG1-IGF2 pathway causes fetal growth restriction. Genet. Med. 20, 250\u2013258 (2018).","journal-title":"Genet. Med."},{"key":"180_CR11","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2174\/1568009611313030002","volume":"13","author":"M Cheung","year":"2013","unstructured":"Cheung, M. & Testa, J. R. Diverse mechanisms of AKT pathway activation in human malignancy. Curr. Cancer Drug Targets 13, 234\u2013244 (2013).","journal-title":"Curr. Cancer Drug Targets"},{"key":"180_CR12","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nrendo.2015.165","volume":"11","author":"J Baron","year":"2015","unstructured":"Baron, J. et al. Short and tall stature: a new paradigm emerges. Nat. Rev. Endocrinol. 11, 735\u2013746 (2015).","journal-title":"Nat. Rev. Endocrinol."},{"key":"180_CR13","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMoa1408028","volume":"371","author":"G Trivellin","year":"2014","unstructured":"Trivellin, G. et al. Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation. N. Engl. J. Med. 371, 2363\u20132374 (2014).","journal-title":"N. Engl. J. Med."},{"key":"180_CR14","unstructured":"Ben Harouch, S., Klar, A. & Falik Zaccai, T. C. INSR-related severe syndromic insulin resistance. GeneReviews \nhttps:\/\/www.ncbi.nlm.nih.gov\/books\/NBK476444\n\n (updated 25 Jan 2018)."},{"key":"180_CR15","unstructured":"Temple, I. K. & Mackay, D. J. G. Diabetes mellitus, 6q24-related transient neonatal. GeneReviews \nhttps:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1534\n\n (updated 13 Sep 2018)."},{"key":"180_CR16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fendo.2016.00029","volume":"7","author":"A Nessa","year":"2016","unstructured":"Nessa, A., Rahman, S. A. & Hussain, K. Hyperinsulinemic hypoglycemia - the molecular mechanisms. Front. Endocrinol. (Lausanne) 7, 29 (2016).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"180_CR17","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00438-015-1015-9","volume":"290","author":"D Albuquerque","year":"2015","unstructured":"Albuquerque, D., Stice, E., Rodriguez-Lopez, R., Manco, L. & Nobrega, C. Current review of genetics of human obesity: from molecular mechanisms to an evolutionary perspective. Mol. Genet. Genomics 290, 1191\u20131221 (2015).","journal-title":"Mol. Genet. Genomics"},{"key":"180_CR18","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/ajmg.a.38266","volume":"173","author":"JM Kalish","year":"2017","unstructured":"Kalish, J. M. et al. Nomenclature and definition in asymmetric regional body overgrowth. Am. J. Med. Genet. A 173, 1735\u20131738 (2017).","journal-title":"Am. J. Med. Genet. A"},{"key":"180_CR19","unstructured":"Beckwith, J. B. in Annual Meeting of Western Society of Pediatric Research (WSPR, Los Angeles, California, 1963)."},{"key":"180_CR20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00473503","volume":"106","author":"HR Wiedemann","year":"1969","unstructured":"Wiedemann, H. R. The EMG-syndrome: exomphalos, macroglossia, gigantism and disturbed carbohydrate metabolism [German]. Z. Kinderheilkd 106, 171\u2013185 (1969).","journal-title":"Z. Kinderheilkd"},{"key":"180_CR21","unstructured":"Shuman, C., Beckwith, J. B. & Weksberg, R. Beckwith-Wiedemann syndrome. GeneReviews \nhttps:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1394\n\n (updated 11 Aug 2016)."},{"key":"180_CR22","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.placenta.2009.03.013","volume":"30","author":"V Romanelli","year":"2009","unstructured":"Romanelli, V. et al. CDKN1C mutations in HELLP\/preeclamptic mothers of Beckwith-Wiedemann Syndrome (BWS) patients. Placenta 30, 551\u2013554 (2009).","journal-title":"Placenta"},{"key":"180_CR23","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/jmedgenet-2013-101691","volume":"50","author":"F Brioude","year":"2013","unstructured":"Brioude, F. et al. CDKN1C mutation affecting the PCNA-binding domain as a cause of familial Russell Silver syndrome. J. Med. Genet. 50, 823\u2013830 (2013).","journal-title":"J. Med. Genet."},{"key":"180_CR24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nrendo.2017.166","volume":"14","author":"F Brioude","year":"2018","unstructured":"Brioude, F. et al. Expert consensus document: clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome: an international consensus statement. Nat. Rev. Endocrinol. 14, 229\u2013249 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"180_CR25","volume":"7","author":"T Eggermann","year":"2015","unstructured":"Eggermann, T. et al. Imprinting disorders: a group of congenital disorders with overlapping patterns of molecular changes affecting imprinted loci. Clin. Epigenetics 7, 123 (2015).","journal-title":"Clin. Epigenetics"},{"key":"180_CR26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/jmedgenet-2017-104919","volume":"55","author":"S Heide","year":"2018","unstructured":"Heide, S. et al. Chromosomal rearrangements in the 11p15 imprinted region: 17 new 11p15.5 duplications with associated phenotypes and putative functional consequences. J. Med. Genet. 55, 205\u2013213 (2018).","journal-title":"J. Med. Genet."},{"key":"180_CR27","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/ajmg.a.36045","volume":"161A","author":"JM Kalish","year":"2013","unstructured":"Kalish, J. M. et al. Clinical features of three girls with mosaic genome-wide paternal uniparental isodisomy. Am. J. Med. Genet. A 161A, 1929\u20131939 (2013).","journal-title":"Am. J. Med. Genet. A"},{"key":"180_CR28","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/ejhg.2013.132","volume":"22","author":"T Eggermann","year":"2014","unstructured":"Eggermann, T. et al. Clinical utility gene card for: Beckwith-Wiedemann Syndrome. Eur. J. Hum. Genet. 22, 435 (2014).","journal-title":"Eur. J. Hum. Genet."},{"key":"180_CR29","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ejhg.2011.166","volume":"20","author":"RL Poole","year":"2012","unstructured":"Poole, R. L. et al. Beckwith-Wiedemann syndrome caused by maternally inherited mutation of an OCT-binding motif in the IGF2\/H19-imprinting control region, ICR1. Eur. J. Hum. Genet. 20, 240\u2013243 (2012).","journal-title":"Eur. J. Hum. Genet."},{"key":"180_CR30","doi-asserted-by":"crossref","first-page":"5763","DOI":"10.1093\/hmg\/ddu290","volume":"23","author":"W Abi Habib","year":"2014","unstructured":"Abi Habib, W. et al. Extensive investigation of the IGF2\/H19 imprinting control region reveals novel OCT4\/SOX2 binding site defects associated with specific methylation patterns in Beckwith-Wiedemann syndrome. Hum. Mol. Genet. 23, 5763\u20135773 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"180_CR31","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/pd.4555","volume":"35","author":"KO Kagan","year":"2015","unstructured":"Kagan, K. O. et al. Novel fetal and maternal sonographic findings in confirmed cases of Beckwith-Wiedemann syndrome. Prenat. Diagn. 35, 394\u2013399 (2015).","journal-title":"Prenat. Diagn."},{"key":"180_CR32","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/humu.22623","volume":"35","author":"S Azzi","year":"2014","unstructured":"Azzi, S. et al. Complex tissue-specific epigenotypes in Russell-Silver Syndrome associated with 11p15 ICR1 hypomethylation. Hum. Mutat. 35, 1211\u20131220 (2014).","journal-title":"Hum. Mutat."},{"key":"180_CR33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrendo.2016.138","volume":"13","author":"EL Wakeling","year":"2017","unstructured":"Wakeling, E. L. et al. Diagnosis and management of Silver-Russell syndrome: first international consensus statement. Nat. Rev. Endocrinol. 13, 105\u2013124 (2017).","journal-title":"Nat. Rev. Endocrinol."},{"key":"180_CR34","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1210\/jc.2017-02152","volume":"103","author":"S Geoffron","year":"2018","unstructured":"Geoffron, S. et al. Chromosome 14q32.2 imprinted region disruption as an alternative molecular diagnosis of Silver-Russell syndrome. J. Clin. Endocrinol. Metab. 103, 2436\u20132446 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"180_CR35","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ng.187","volume":"40","author":"DJ Mackay","year":"2008","unstructured":"Mackay, D. J. et al. Hypomethylation of multiple imprinted loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57. Nat. Genet. 40, 949\u2013951 (2008).","journal-title":"Nat. Genet."},{"key":"180_CR36","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/humu.22352","volume":"34","author":"S Maupetit-Mehouas","year":"2013","unstructured":"Maupetit-Mehouas, S. et al. Simultaneous hyper- and hypomethylation at imprinted loci in a subset of patients with GNAS epimutations underlies a complex and different mechanism of multilocus methylation defect in pseudohypoparathyroidism type 1b. Hum. Mutat. 34, 1172\u20131180 (2013).","journal-title":"Hum. Mutat."},{"key":"180_CR37","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41574-018-0042-0","volume":"14","author":"G Mantovani","year":"2018","unstructured":"Mantovani, G. et al. Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement. Nat. Rev. Endocrinol. 14, 476\u2013500 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"180_CR38","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1002\/ajmg.a.36049","volume":"161A","author":"RL Poole","year":"2013","unstructured":"Poole, R. L. et al. Targeted methylation testing of a patient cohort broadens the epigenetic and clinical description of imprinting disorders. Am. J. Med. Genet. A 161A, 2174\u20132182 (2013).","journal-title":"Am. J. Med. Genet. A"},{"key":"180_CR39","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms9086","volume":"6","author":"LE Docherty","year":"2015","unstructured":"Docherty, L. E. et al. Mutations in NLRP5 are associated with reproductive wastage and multilocus imprinting disorders in humans. Nat. Commun. 6, 8086 (2015).","journal-title":"Nat. Commun."},{"key":"180_CR40","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/jmedgenet-2017-105190","volume":"55","author":"M Begemann","year":"2018","unstructured":"Begemann, M. et al. Maternal variants in NLRP and other maternal effect proteins are associated with multilocus imprinting disturbance in offspring. J. Med. Genet. 55, 497\u2013504 (2018).","journal-title":"J. Med. Genet."},{"key":"180_CR41","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1086\/382897","volume":"74","author":"EL Niemitz","year":"2004","unstructured":"Niemitz, E. L. & Feinberg, A. P. Epigenetics and assisted reproductive technology: a call for investigation. Am. J. Hum. Genet. 74, 599\u2013609 (2004).","journal-title":"Am. J. Hum. Genet."},{"key":"180_CR42","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1136\/jmg.2006.042135","volume":"43","author":"S Rossignol","year":"2006","unstructured":"Rossignol, S. et al. The epigenetic imprinting defect of patients with Beckwith-Wiedemann syndrome born after assisted reproductive technology is not restricted to the 11p15 region. J. Med. Genet. 43, 902\u2013907 (2006).","journal-title":"J. Med. Genet."},{"key":"180_CR43","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/jmg.40.1.62","volume":"40","author":"ER Maher","year":"2003","unstructured":"Maher, E. R. et al. Beckwith-Wiedemann syndrome and assisted reproduction technology (ART). J. Med. Genet. 40, 62\u201364 (2003).","journal-title":"J. Med. Genet."},{"key":"180_CR44","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1086\/341096","volume":"71","author":"GF Cox","year":"2002","unstructured":"Cox, G. F. et al. Intracytoplasmic sperm injection may increase the risk of imprinting defects. Am. J. Hum. Genet. 71, 162\u2013164 (2002).","journal-title":"Am. J. Hum. Genet."},{"key":"180_CR45","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10815-018-1173-x","volume":"35","author":"VK Cortessis","year":"2018","unstructured":"Cortessis, V. K. et al. Comprehensive meta-analysis reveals association between multiple imprinting disorders and conception by assisted reproductive technology. J. Assist. Reprod. Genet. 35, 943\u2013952 (2018).","journal-title":"J. Assist. Reprod. Genet."},{"key":"180_CR46","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-4311","volume":"140","author":"A Mussa","year":"2017","unstructured":"Mussa, A. et al. Assisted reproductive techniques and risk of Beckwith-Wiedemann syndrome. Pediatrics 140, e20164311 (2017).","journal-title":"Pediatrics"},{"key":"180_CR47","first-page":"18","volume":"11","author":"JL Simpson","year":"1975","unstructured":"Simpson, J. L., Landey, S., New, M. & German, J. A previously unrecognized X-linked syndrome of dysmorphia. Birth Defects Orig. Artic. Ser. 11, 18\u201324 (1975).","journal-title":"Birth Defects Orig. Artic. Ser."},{"key":"180_CR48","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/BF00291401","volume":"67","author":"A Behmel","year":"1984","unstructured":"Behmel, A., Plochl, E. & Rosenkranz, W. A new X-linked dysplasia gigantism syndrome: identical with the Simpson dysplasia syndrome? Hum. Genet. 67, 409\u2013413 (1984).","journal-title":"Hum. Genet."},{"key":"180_CR49","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/ajmg.1320170128","volume":"17","author":"M Golabi","year":"1984","unstructured":"Golabi, M. & Rosen, L. A new X-linked mental retardation-overgrowth syndrome. Am. J. Med. Genet. 17, 345\u2013358 (1984).","journal-title":"Am. J. Med. Genet."},{"key":"180_CR50","unstructured":"Sajorda, B. J., Gonzalez-Gandolfi, C. X., Hathaway, E. R. & Kalish, J. M. Simpson-Golabi-Behmel syndrome type\u00a01. GeneReviews \nhttps:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1219\n\n (updated 29 Nov 2018)."},{"key":"180_CR51","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ajmg.c.31360","volume":"163C","author":"E Cottereau","year":"2013","unstructured":"Cottereau, E. et al. Phenotypic spectrum of Simpson-Golabi-Behmel syndrome in a series of 42 cases with a mutation in GPC3 and review of the literature. Am. J. Med. Genet. C Semin. Med. Genet. 163C, 92\u2013105 (2013).","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"180_CR52","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-014-0138-0","volume":"9","author":"J Tenorio","year":"2014","unstructured":"Tenorio, J. et al. Simpson-Golabi-Behmel syndrome types I and II. Orphanet J. Rare Dis. 9, 138 (2014).","journal-title":"Orphanet J. Rare Dis."},{"key":"180_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-019-0339-z","author":"ML Vuillaume","year":"2019","unstructured":"Vuillaume, M. L. et al. CUGC for Simpson-Golabi-Behmel syndrome (SGBS). Eur. J. Hum. Genet. \nhttps:\/\/doi.org\/10.1038\/s41431-019-0339-z\n\n (2019).","journal-title":"Eur. J. Hum. Genet."},{"key":"180_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2018.07.022","author":"S Schirwani","year":"2018","unstructured":"Schirwani, S. et al. Duplications of GPC3 and GPC4 genes in symptomatic demale carriers of Simpson-Golabi-Behmel syndromes type 1. Eur. J. Med. Genet. \nhttps:\/\/doi.org\/10.1016\/j.ejmg.2018.07.022\n\n (2018).","journal-title":"Eur. J. Med. Genet."},{"key":"180_CR55","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ng0396-241","volume":"12","author":"G Pilia","year":"1996","unstructured":"Pilia, G. et al. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat. Genet. 12, 241\u2013247 (1996).","journal-title":"Nat. Genet."},{"key":"180_CR56","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/humu.23428","volume":"39","author":"ML Vuillaume","year":"2018","unstructured":"Vuillaume, M. L. et al. Mutation update for the GPC3 gene involved in Simpson-Golabi-Behmel syndrome and review of the literature. Hum. Mutat. 39, 790\u2013805 (2018).","journal-title":"Hum. Mutat."},{"key":"180_CR57","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.devcel.2008.03.006","volume":"14","author":"MI Capurro","year":"2008","unstructured":"Capurro, M. I. et al. Glypican-3 inhibits Hedgehog signaling during development by competing with patched for Hedgehog binding. Dev. Cell 14, 700\u2013711 (2008).","journal-title":"Dev. Cell"},{"key":"180_CR58","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1111\/febs.12126","volume":"280","author":"J Filmus","year":"2013","unstructured":"Filmus, J. & Capurro, M. Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma. FEBS J. 280, 2471\u20132476 (2013).","journal-title":"FEBS J."},{"key":"180_CR59","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/ajmg.a.32669","volume":"149A","author":"W Shi","year":"2009","unstructured":"Shi, W. & Filmus, J. A patient with the Simpson-Golabi-Behmel syndrome displays a loss-of-function point mutation in GPC3 that inhibits the attachment of this proteoglycan to the cell surface. Am. J. Med. Genet. A 149A, 552\u2013554 (2009).","journal-title":"Am. J. Med. Genet. A"},{"key":"180_CR60","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/hmg\/9.9.1321","volume":"9","author":"M Veugelers","year":"2000","unstructured":"Veugelers, M. et al. Mutational analysis of the GPC3\/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene. Hum. Mol. Genet. 9, 1321\u20131328 (2000).","journal-title":"Hum. Mol. Genet."},{"key":"180_CR61","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJM196407162710301","volume":"271","author":"JF Sotos","year":"1964","unstructured":"Sotos, J. F., Dodge, P. R., Muirhead, D., Crawford, J. D. & Talbot, N. B. Cerebral gigantism in childhood. a syndrome of excessively rapid growth and acromegalic features and a nonprogressive neurologic disorder. N. Engl. J. Med. 271, 109\u2013116 (1964).","journal-title":"N. Engl. J. Med."},{"key":"180_CR62","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/432082","volume":"77","author":"K Tatton-Brown","year":"2005","unstructured":"Tatton-Brown, K. et al. Genotype-phenotype associations in Sotos syndrome: an analysis of 266 individuals with NSD1 aberrations. Am. J. Hum. Genet. 77, 193\u2013204 (2005).","journal-title":"Am. J. Hum. Genet."},{"key":"180_CR63","unstructured":"Tatton-Brown, K., Cole, T. R. P. & Rahman, N. Sotos syndrome. GeneReviews \nhttps:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1479\n\n (updated 19 Nov 2015)."},{"key":"180_CR64","volume":"11","author":"C Lane","year":"2016","unstructured":"Lane, C., Milne, E. & Freeth, M. Cognition and behaviour in Sotos syndrome: a systematic review. PLOS ONE 11, e0149189 (2016).","journal-title":"PLOS ONE"},{"key":"180_CR65","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10803-016-2941-z","volume":"47","author":"C Lane","year":"2017","unstructured":"Lane, C., Milne, E. & Freeth, M. Characteristics of autism spectrum disorder in Sotos syndrome. J. Autism Dev. Disord. 47, 135\u2013143 (2017).","journal-title":"J. Autism Dev. Disord."},{"key":"180_CR66","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1111\/j.1528-1167.2012.03418.x","volume":"53","author":"F Nicita","year":"2012","unstructured":"Nicita, F. et al. Seizures and epilepsy in Sotos syndrome: analysis of 19 caucasian patients with long-term follow-up. Epilepsia 53, e102\u2013e105 (2012).","journal-title":"Epilepsia"},{"key":"180_CR67","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/jmg.31.1.20","volume":"31","author":"TR Cole","year":"1994","unstructured":"Cole, T. R. & Hughes, H. E. Sotos syndrome: a study of the diagnostic criteria and natural history. J. Med. Genet. 31, 20\u201332 (1994).","journal-title":"J. Med. Genet."},{"key":"180_CR68","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng863","volume":"30","author":"N Kurotaki","year":"2002","unstructured":"Kurotaki, N. et al. Haploinsufficiency of NSD1 causes Sotos syndrome. Nat. Genet. 30, 365\u2013366 (2002).","journal-title":"Nat. Genet."},{"key":"180_CR69","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1093\/emboj\/cdg288","volume":"22","author":"GV Rayasam","year":"2003","unstructured":"Rayasam, G. V. et al. NSD1 is essential for early post-implantation development and has a catalytically active SET domain. EMBO J. 22, 3153\u20133163 (2003).","journal-title":"EMBO J."},{"key":"180_CR70","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/jmedgenet-2014-102402","volume":"51","author":"A Luscan","year":"2014","unstructured":"Luscan, A. et al. Mutations in SETD2 cause a novel overgrowth condition. J. Med. Genet. 51, 512\u2013517 (2014).","journal-title":"J. Med. Genet."},{"key":"180_CR71","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/jmedgenet-2015-103638","volume":"53","author":"C Tlemsani","year":"2016","unstructured":"Tlemsani, C. et al. SETD2 and DNMT3A screen in the Sotos-like syndrome French cohort. J. Med. Genet. 53, 743\u2013751 (2016).","journal-title":"J. Med. Genet."},{"key":"180_CR72","first-page":"139","volume":"15","author":"M Almuriekhi","year":"2015","unstructured":"Almuriekhi, M. et al. Loss-of-function mutation in APC2 causes Sotos syndrome features. Cell Rep. 15, 139\u2013134 (2015).","journal-title":"Cell Rep."},{"key":"180_CR73","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/sj.emboj.7601967","volume":"27","author":"JW Edmunds","year":"2008","unstructured":"Edmunds, J. W., Mahadevan, L. C. & Clayton, A. L. Dynamic histone H3 methylation during gene induction: HYPB\/Setd2 mediates all H3K36 trimethylation. EMBO J. 27, 406\u2013420 (2008).","journal-title":"EMBO J."},{"key":"180_CR74","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/embor.2009.218","volume":"10","author":"J Otani","year":"2009","unstructured":"Otani, J. et al. Structural basis for recognition of H3K4 methylation status by the DNA methyltransferase 3A ATRX-DNMT3-DNMT3L domain. EMBO Rep. 10, 1235\u20131241 (2009).","journal-title":"EMBO Rep."},{"key":"180_CR75","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1126\/science.1227764","volume":"338","author":"BJ O\u2019Roak","year":"2012","unstructured":"O\u2019Roak, B. J. et al. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 338, 1619\u20131622 (2012).","journal-title":"Science"},{"key":"180_CR76","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature13908","volume":"515","author":"I Iossifov","year":"2014","unstructured":"Iossifov, I. et al. The contribution of de novo coding mutations to autism spectrum disorder. Nature 515, 216\u2013221 (2014).","journal-title":"Nature"},{"key":"180_CR77","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1007\/s10803-015-2484-8","volume":"45","author":"HS Lumish","year":"2015","unstructured":"Lumish, H. S., Wynn, J., Devinsky, O. & Chung, W. K. Brief report: SETD2 mutation in a child with autism, intellectual disabilities and epilepsy. J. Autism Dev. Disord. 45, 3764\u20133770 (2015).","journal-title":"J. Autism Dev. Disord."},{"key":"180_CR78","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ng.2917","volume":"46","author":"K Tatton-Brown","year":"2014","unstructured":"Tatton-Brown, K. et al. Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability. Nat. Genet. 46, 385\u2013388 (2014).","journal-title":"Nat. Genet."},{"key":"180_CR79","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/cge.12878","volume":"91","author":"B Xin","year":"2017","unstructured":"Xin, B. et al. Novel DNMT3A germline mutations are associated with inherited Tatton-Brown-Rahman syndrome. Clin. Genet. 91, 623\u2013628 (2017).","journal-title":"Clin. Genet."},{"key":"180_CR80","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/ajmg.a.37995","volume":"173","author":"R Kosaki","year":"2017","unstructured":"Kosaki, R., Terashima, H., Kubota, M. & Kosaki, K. Acute myeloid leukemia-associated DNMT3A p. Arg882His mutation in a patient with tatton-Brown-Rahman overgrowth syndrome as a constitutional mutation. Am. J. Med. Genet. A 173, 250\u2013253 (2017).","journal-title":"Am. J. Med. Genet. A"},{"key":"180_CR81","doi-asserted-by":"crossref","first-page":"46","DOI":"10.12688\/wellcomeopenres.14430.1","volume":"3","author":"K Tatton-Brown","year":"2018","unstructured":"Tatton-Brown, K. et al. The Tatton-Brown-Rahman syndrome: a clinical study of 55 individuals with de novo constitutive DNMT3A variants. Wellcome Open Res. 3, 46 (2018).","journal-title":"Wellcome Open Res."},{"key":"180_CR82","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ajhg.2010.07.001","volume":"87","author":"V Malan","year":"2010","unstructured":"Malan, V. et al. Distinct effects of allelic NFIX mutations on nonsense-mediated mRNA decay engender either a Sotos-like or a Marshall-Smith syndrome. Am. J. Hum. Genet. 87, 189\u2013198 (2010).","journal-title":"Am. J. Hum. Genet."},{"key":"180_CR83","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/ejhg.2014.162","volume":"23","author":"M Klaassens","year":"2015","unstructured":"Klaassens, M. et al. Malan syndrome: Sotos-like overgrowth with de novo NFIX sequence variants and deletions in six new patients and a review of the literature. Eur. J. Hum. Genet. 23, 610\u2013615 (2015).","journal-title":"Eur. J. Hum. Genet."},{"key":"180_CR84","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/pr.2015.135","volume":"78","author":"F Martinez","year":"2015","unstructured":"Martinez, F. et al. Novel mutations of NFIX gene causing Marshall-Smith syndrome or Sotos-like syndrome: one gene, two phenotypes. Pediatr. Res. 78, 533\u2013539 (2015).","journal-title":"Pediatr. Res."},{"key":"180_CR85","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrg2520","volume":"10","author":"JF Bateman","year":"2009","unstructured":"Bateman, J. F., Boot-Handford, R. P. & Lamande, S. R. Genetic diseases of connective tissues: cellular and extracellular effects of ECM mutations. Nat. Rev. Genet. 10, 173\u2013183 (2009).","journal-title":"Nat. Rev. Genet."},{"key":"180_CR86","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.87623","volume":"1","author":"G Mirzaa","year":"2016","unstructured":"Mirzaa, G. et al. PIK3CA-associated developmental disorders exhibit distinct classes of mutations with variable expression and tissue distribution. JCI Insight 1, e87623 (2016).","journal-title":"JCI Insight"},{"key":"180_CR87","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1002\/ajmg.a.36229","volume":"161A","author":"K Tatton-Brown","year":"2013","unstructured":"Tatton-Brown, K. et al. Weaver syndrome and EZH2 mutations: clarifying the clinical phenotype. Am. J. Med. Genet. A 161A, 2972\u20132980 (2013).","journal-title":"Am. J. Med. Genet. A"},{"key":"180_CR88","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1076997","volume":"298","author":"R Cao","year":"2002","unstructured":"Cao, R. et al. Role of histone H3 lysine 27 methylation in polycomb-group silencing. Science 298, 1039\u20131043 (2002).","journal-title":"Science"},{"key":"180_CR89","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/jhg.2016.51","volume":"61","author":"AS Cohen","year":"2016","unstructured":"Cohen, A. S. & Gibson, W. T. EED-associated overgrowth in a second male patient. J. Hum. Genet. 61, 831\u2013834 (2016).","journal-title":"J. Hum. Genet."},{"key":"180_CR90","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/jhg.2015.26","volume":"60","author":"AS Cohen","year":"2015","unstructured":"Cohen, A. S. et al. A novel mutation in EED associated with overgrowth. J. Hum. Genet. 60, 339\u2013342 (2015).","journal-title":"J. Hum. Genet."},{"key":"180_CR91","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/ajmg.a.38055","volume":"173A","author":"E Cooney","year":"2017","unstructured":"Cooney, E., Bi, W., Schlesinger, A. E., Vinson, S. & Potocki, L. Novel EED mutation in patient with Weaver syndrome. Am. J. Med. Genet. A 173A, 541\u2013545 (2017).","journal-title":"Am. J. Med. Genet. A"},{"key":"180_CR92","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ajmg.1320190120","volume":"19","author":"G Neri","year":"1984","unstructured":"Neri, G., Martini-Neri, M. E., Katz, B. E. & Opitz, J. M. The Perlman syndrome: familial renal dysplasia with Wilms tumor, fetal gigantism and multiple congenital anomalies. Am. J. Med. Genet. 19, 195\u2013207 (1984).","journal-title":"Am. J. Med. Genet."},{"key":"180_CR93","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1002\/ajmg.a.32391","volume":"146A","author":"JL Alessandri","year":"2008","unstructured":"Alessandri, J. L. et al. Perlman syndrome: report, prenatal findings and review. Am. J. Med. Genet. A 146A, 2532\u20132537 (2008).","journal-title":"Am. J. Med. Genet. A"},{"key":"180_CR94","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/ng.1071","volume":"44","author":"D Astuti","year":"2012","unstructured":"Astuti, D. et al. Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility. Nat. Genet. 44, 277\u2013284 (2012).","journal-title":"Nat. Genet."},{"key":"180_CR95","first-page":"10437","volume":"44","author":"A Labno","year":"2016","unstructured":"Labno, A. et al. Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs. Nucleic Acids Res. 44, 10437\u201310453 (2016).","journal-title":"Nucleic Acids Res."},{"key":"180_CR96","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrclinonc.2018.28","volume":"15","author":"F Janku","year":"2018","unstructured":"Janku, F., Yap, T. A. & Meric-Bernstam, F. Targeting the PI3K pathway in cancer: are we making headway? Nat. Rev. Clin. Oncol. 15, 273\u2013291 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"180_CR97","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/jnci\/djt277","volume":"105","author":"R Pilarski","year":"2013","unstructured":"Pilarski, R. et al. Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria. J. Natl Cancer Inst. 105, 1607\u20131616 (2013).","journal-title":"J. Natl Cancer Inst."},{"key":"180_CR98","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/ajmg.a.36552","volume":"164A","author":"KM Keppler-Noreuil","year":"2014","unstructured":"Keppler-Noreuil, K. M. et al. Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum. Am. J. Med. Genet. A 164A, 1713\u20131733 (2014).","journal-title":"Am. J. Med. Genet. A"},{"key":"180_CR99","doi-asserted-by":"crossref","unstructured":"Biesecker, L. G. & Sapp, J. C. Proteus syndrome. GeneReviews \nhttps:\/\/www.ncbi.nlm.nih.gov\/books\/NBK99495\n\n (updated 10 Jan 2019).","DOI":"10.1093\/med\/9780190944896.003.0011"},{"key":"180_CR100","unstructured":"Mirzaa, G., Conway, R., Graham, J. M. Jr & Dobyns, W. B. PIK3CA-related segmental overgrowth. GeneReviews \nhttps:\/\/www.ncbi.nlm.nih.gov\/books\/NBK153722\n\n (updated 15 Aug 2013)."},{"key":"180_CR101","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/cge.13195","volume":"93","author":"ME Michel","year":"2018","unstructured":"Michel, M. E. et al. Causal somatic mutations in urine DNA from persons with the CLOVES subgroup of the PIK3CA-related overgrowth spectrum. Clin. Genet. 93, 1075\u20131080 (2018).","journal-title":"Clin. Genet."},{"key":"180_CR102","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/gim.2016.220","volume":"19","author":"P Kuentz","year":"2017","unstructured":"Kuentz, P. et al. Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommendations for genetic testing. Genet. Med. 19, 989\u2013997 (2017).","journal-title":"Genet. Med."},{"key":"180_CR103","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.det.2016.07.001","volume":"35","author":"N Nathan","year":"2017","unstructured":"Nathan, N., Keppler-Noreuil, K. M., Biesecker, L. G., Moss, J. & Darling, T. N. Mosaic disorders of the PI3K\/PTEN\/AKT\/TSC\/mTORC1 signaling pathway. Dermatol. Clin. 35, 51\u201360 (2017).","journal-title":"Dermatol. Clin."},{"key":"180_CR104","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1104017","volume":"365","author":"MJ Lindhurst","year":"2011","unstructured":"Lindhurst, M. J. et al. A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N. Engl. J. Med. 365, 611\u2013619 (2011).","journal-title":"N. Engl. J. Med."},{"key":"180_CR105","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1126\/science.1210878","volume":"334","author":"K Hussain","year":"2011","unstructured":"Hussain, K. et al. An activating mutation of AKT2 and human hypoglycemia. Science 334, 474 (2011).","journal-title":"Science"},{"key":"180_CR106","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0140-6736(01)05412-5","volume":"358","author":"X Zhou","year":"2001","unstructured":"Zhou, X. et al. Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndromes. Lancet 358, 210\u2013211 (2001).","journal-title":"Lancet"},{"key":"180_CR107","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/S0140-6736(01)07109-4","volume":"358","author":"LG Biesecker","year":"2001","unstructured":"Biesecker, L. G., Rosenberg, M. J., Vacha, S., Turner, J. T. & Cohen, M. M. PTEN mutations and proteus syndrome. Lancet 358, 2079\u20132080 (2001).","journal-title":"Lancet"},{"key":"180_CR108","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/ng.2331","volume":"44","author":"JB Riviere","year":"2012","unstructured":"Riviere, J. B. et al. De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nat. Genet. 44, 934\u2013940 (2012).","journal-title":"Nat. Genet."},{"key":"180_CR109","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/ng.2948","volume":"46","author":"G Mirzaa","year":"2014","unstructured":"Mirzaa, G. et al. De novo CCND2 mutations leading to stabilization of cyclin D2 cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome. Nat. Genet. 46, 510\u2013515 (2014).","journal-title":"Nat. Genet."},{"key":"180_CR110","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1158\/1078-0432.CCR-17-0408","volume":"23","author":"CP Kratz","year":"2017","unstructured":"Kratz, C. P. et al. Cancer screening recommendations for individuals with Li-Fraumeni syndrome. Clin. Cancer Res. 23, e38\u2013e45 (2017).","journal-title":"Clin. Cancer Res."},{"key":"180_CR111","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","volume":"25","author":"S Chen","year":"2007","unstructured":"Chen, S. & Parmigiani, G. Meta-analysis of BRCA1 and BRCA2 penetrance. J. Clin. Oncol. 25, 1329\u20131333 (2007).","journal-title":"J. Clin. Oncol."},{"key":"180_CR112","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/317260a0","volume":"317","author":"J Scott","year":"1985","unstructured":"Scott, J. et al. Insulin-like growth factor-II gene expression in Wilms\u2019 tumour and embryonic tissues. Nature 317, 260\u2013262 (1985).","journal-title":"Nature"},{"key":"180_CR113","first-page":"1444","volume":"78","author":"C Gicquel","year":"1994","unstructured":"Gicquel, C. et al. Rearrangements at the 11p15 locus and overexpression of insulin-like growth factor-II gene in sporadic adrenocortical tumors. J. Clin. Endocrinol. Metab. 78, 1444\u20131453 (1994).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"180_CR114","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/0046-8177(95)90005-5","volume":"26","author":"SN Akmal","year":"1995","unstructured":"Akmal, S. N., Yun, K., MacLay, J., Higami, Y. & Ikeda, T. Insulin-like growth factor 2 and insulin-like growth factor binding protein 2 expression in hepatoblastoma. Hum. Pathol. 26, 846\u2013851 (1995).","journal-title":"Hum. Pathol."},{"key":"180_CR115","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1073\/pnas.92.6.2159","volume":"92","author":"T Taniguchi","year":"1995","unstructured":"Taniguchi, T., Sullivan, M. J., Ogawa, O. & Reeve, A. E. Epigenetic changes encompassing the IGF2\/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor. Proc. Natl Acad. Sci. USA 92, 2159\u20132163 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"180_CR116","first-page":"1836","volume":"55","author":"S Rainier","year":"1995","unstructured":"Rainier, S., Dobry, C. J. & Feinberg, A. P. Loss of imprinting in hepatoblastoma. Cancer Res. 55, 1836\u20131838 (1995).","journal-title":"Cancer Res."},{"key":"180_CR117","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jpeds.2016.05.038","volume":"176","author":"A Mussa","year":"2016","unstructured":"Mussa, A. et al. Cancer risk in Beckwith-Wiedemann Syndrome: a systematic review and meta-analysis outlining a novel (epi)genotype specific histotype targeted screening protocol. J. Pediatr. 176, 142\u2013149 (2016).","journal-title":"J. Pediatr."},{"key":"180_CR118","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1002\/ajmg.a.37801","volume":"170A","author":"SM Maas","year":"2016","unstructured":"Maas, S. M. et al. Phenotype, cancer risk, and surveillance in Beckwith-Wiedemann syndrome depending on molecular genetic subgroups. Am. J. Med. Genet. A 170A, 2248\u20132260 (2016).","journal-title":"Am. J. Med. Genet. A"},{"key":"180_CR119","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41431-017-0074-2","volume":"26","author":"F Brioude","year":"2018","unstructured":"Brioude, F. et al. Revisiting Wilms tumour surveillance in Beckwith-Wiedemann syndrome with IC2 methylation loss, reply. Eur. J. Hum. Genet. 26, 471\u2013472 (2018).","journal-title":"Eur. J. Hum. Genet."},{"key":"180_CR120","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1158\/1078-0432.CCR-17-0710","volume":"23","author":"JM Kalish","year":"2017","unstructured":"Kalish, J. M. et al. Surveillance recommendations for children with overgrowth syndromes and predisposition to Wilms tumors and hepatoblastoma. Clin. Cancer Res. 23, e115\u2013e122 (2017).","journal-title":"Clin. Cancer Res."},{"key":"180_CR121","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ajmg.c.30064","volume":"137C","author":"P Lapunzina","year":"2005","unstructured":"Lapunzina, P. Risk of tumorigenesis in overgrowth syndromes: a comprehensive review. Am. J. Med. Genet. C Semin. Med. Genet. 137C, 53\u201371 (2005).","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"180_CR122","doi-asserted-by":"crossref","first-page":"a026708","DOI":"10.1101\/cshperspect.a026708","volume":"7","author":"RL Bennett","year":"2017","unstructured":"Bennett, R. L., Swaroop, A., Troche, C. & Licht, J. D. The role of nuclear receptor-binding SET domain family histone lysine methyltransferases in cancer. Cold Spring Harb. Perspect. Med. 7, a026708 (2017).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"180_CR123","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1111\/cas.13655","volume":"109","author":"M Nakagawa","year":"2018","unstructured":"Nakagawa, M. & Kitabayashi, I. Oncogenic roles of enhancer of zeste homolog 1\/2 in hematological malignancies. Cancer Sci. 109, 2342\u20132348 (2018).","journal-title":"Cancer Sci."},{"key":"180_CR124","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1158\/1078-0432.CCR-17-0631","volume":"23","author":"A Villani","year":"2017","unstructured":"Villani, A. et al. Recommendations for cancer surveillance in individuals with RASopathies and other rare genetic conditions with increased cancer risk. Clin. Cancer Res. 23, e83\u2013e90 (2017).","journal-title":"Clin. Cancer Res."},{"key":"180_CR125","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ajmg.c.31364","volume":"163C","author":"J Mester","year":"2013","unstructured":"Mester, J. & Eng, C. When overgrowth bumps into cancer: the PTEN-opathies. Am. J. Med. Genet. C Semin. Med. Genet. 163C, 114\u2013121 (2013).","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"180_CR126","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1210\/jc.2010-1315","volume":"96","author":"JR Smith","year":"2011","unstructured":"Smith, J. R. et al. Thyroid nodules and cancer in children with PTEN hamartoma tumor syndrome. J. Clin. Endocrinol. Metab. 96, 34\u201337 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"180_CR127","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1158\/1078-0432.CCR-17-0629","volume":"23","author":"KAP Schultz","year":"2017","unstructured":"Schultz, K. A. P. et al. PTEN, DICER1, FH, and their associated tumor susceptibility syndromes: clinical features, genetics, and surveillance recommendations in childhood. Clin. Cancer Res. 23, e76\u2013e82 (2017).","journal-title":"Clin. Cancer Res."},{"key":"180_CR128","doi-asserted-by":"crossref","first-page":"9","DOI":"10.6004\/jnccn.2017.0003","volume":"15","author":"MB Daly","year":"2017","unstructured":"Daly, M. B. et al. NCCN guidelines insights: genetic\/familial high-risk assessment: breast and ovarian, version 2.2017. J. Natl Compr. Canc. Netw. 15, 9\u201320 (2017).","journal-title":"J. Natl Compr. Canc. Netw."},{"key":"180_CR129","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1002\/ajmg.a.37758","volume":"170A","author":"KW Gripp","year":"2016","unstructured":"Gripp, K. W. et al. Nephroblastomatosis or Wilms tumor in a fourth patient with a somatic PIK3CA mutation. Am. J. Med. Genet. A 170A, 2559\u20132569 (2016).","journal-title":"Am. J. Med. Genet. A"},{"key":"180_CR130","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ajmg.c.30060","volume":"137C","author":"G Baujat","year":"2005","unstructured":"Baujat, G. et al. Clinical and molecular overlap in overgrowth syndromes. Am. J. Med. Genet. C Semin. Med. Genet. 137C, 4\u201311 (2005).","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"180_CR131","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1086\/383093","volume":"74","author":"G Baujat","year":"2004","unstructured":"Baujat, G. et al. Paradoxical NSD1 mutations in Beckwith-Wiedemann syndrome and 11p15 anomalies in Sotos syndrome. Am. J. Hum. Genet. 74, 715\u2013720 (2004).","journal-title":"Am. J. Hum. Genet."},{"key":"180_CR132","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jmoldx.2017.04.006","volume":"19","author":"F Chang","year":"2017","unstructured":"Chang, F. et al. Molecular diagnosis of mosaic overgrowth syndromes using a custom-designed next-generation sequencing panel. J. Mol. Diagn. 19, 613\u2013624 (2017).","journal-title":"J. Mol. Diagn."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41574-019-0180-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41574-019-0180-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41574-019-0180-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:46:59Z","timestamp":1684619219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-019-0180-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,6]]},"references-count":132,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["180"],"URL":"https:\/\/doi.org\/10.1038\/s41574-019-0180-z","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,6]]},"assertion":[{"value":"6 March 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}